Based on the evidence available, the
Vaccines Advisory Committee (VAC) of the Spanish Association of Pediatrics reports and comments on the new developments in
vaccines that have taken place in 2005 and recommends some modifications to the vaccination schedule for 2006. In agreement with changes in the product monographs for the meningococcal C
vaccine, the VAC recommends two doses for the three commercially available preparations with a booster dose in the second year of life. The European Medicines Evaluation Agency (EMEA) has temporarily suspended the sale of the
Hexavac vaccine due to doubts about its long-term protection against
hepatitis B. The VAC continues to support the use of these
combined vaccines. Currently only Infranrix Hexa is available in Spain. The recommendation of vaccinating adolescents with a booster dose of
pertussis vaccine via the administration of an acellular preparation of low antigenic load together with the adult
diphtheria and
tetanus vaccine remains valid. Vaccination against
chickenpox in susceptible children aged more than 12 months old continues to be recommended. There is wide coverage for the 7-valent pneumococcal
conjugate vaccine in many areas of Spain. In view of the studies published, the VAC reiterates the need for universal immunization by introducing this
vaccine in the official vaccination schedule. Finally, other
vaccines not included in this schedule are discussed, with special mention of the advisability of
influenza vaccination in children, according to the recommendations of the VAC available at the beginning of each season on the web site of the Spanish Association of Pediatrics www.aeped.es; www. vacunasaep.org.